I am buying now. The reason for thos is there will be a bump up in price and much more attention when both Phase 3 trials are underway. I also like there is no competition, as this medication is a value-add to tratiotional, increasing both of the drugs used to treat the condition, giving an extra 10% effectiveness. Who would not want an extra effect when this is proposed to a patient. The take up will be by all who are insured or can otherwise pay for this value-add treatment
I am buying now. The reason for thos is there will be a bump up...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
81.5¢ |
Change
0.030(3.82%) |
Mkt cap ! $1.003B | |||
| Open | High | Low | Value | Volume |
| 78.5¢ | 82.5¢ | 78.5¢ | $1.203M | 1.499M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5772 | 81.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 82.5¢ | 844 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| OPT (ASX) Chart |